ImaginAb's Unattributed - II Round

ImaginAb raised a round of funding on September 15, 2017.

ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging. The company's antibody fragment platform yields actionable molecular information to gu…

Articles about ImaginAb's Unattributed - II Round: